Modified Oral Rapid Drug Desensitization (ORDD) to Ibrutinib in a Patient with Stage IV Mantle Cell Lymphoma and Early Onset Grade 1 Hypersensitivity Reaction.

Details

Language :

English

ISSN :

00916749

Volume :

139

Database :

Supplemental Index

Journal :

Journal of Allergy & Clinical Immunology

Publication Type :

Academic Journal

Accession number :

121130947

Full Text :

https://doi.org/10.1016/j.jaci.2016.12.180